China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.

A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological conditions such as epilepsy, spinal cord injury, ALS, stroke, and ...

June 2 (UPI) --Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient and recorded neural activity, before removing it 10 minutes ...

The study will evaluate the long-term use of Connexus BCI for its ability to safely restore speech and enable computer control for people with severe motor impairment. Paradromics Inc., a ...

An important milestone for brain-computer interfaces has been achieved. A new peer-reviewed neuroscience study led by researchers at the University of California, Los Angeles (UCLA) demonstrates a ...

Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market The Company stated that these ...

Could a future exist where the brain and artificial intelligence systems communicate as effortlessly as a smartphone connecting to Wi-Fi? This may sound like science fiction, but researchers are ...

An important milestone has been achieved in brain-computer interface (BCI) technology. A new peer-reviewed study published in Nature Biomedical Engineering shows how a high-performance brain-computer ...

Investigational ARC-BCI ® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other movement disabilities ARC-BCI is the world’s first and most ...

China has introduced its first official standards for non-invasive brain-computer interface (BCI) medical devices, signaling a shift from fragmented academic research to formal regulatory oversight ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...